Nocardia anti-GM-CSF autoantibodies autoimmune pulmonary alveolar proteinosis central nervous system infection nocardiosis

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 30 01 2024
accepted: 05 05 2024
medline: 25 6 2024
pubmed: 25 6 2024
entrez: 25 6 2024
Statut: epublish

Résumé

Nocardiosis, a bacterial opportunistic infection caused by We performed a prospective, multicenter, nationwide study in France and included patients with a Twenty patients (18 [90%] male) were included, with a median age of 69 (interquartile range, 44-75) years. The organs most frequently involved were the brain (14/20 [70%]) and the lung (12/20 [60%]). Half of the infections were disseminated (10/20 [50%]). Nocardiosis with anti-GM-CSF autoantibodies is associated with a low mortality rate despite a high incidence of brain involvement. Although the occurrence of aPAP was infrequent during the 1-year follow-up period, long-term clinical data are needed to fully understand the potential relationship between nocardiosis, anti-GM-CSF autoantibodies, and aPAP.

Sections du résumé

Background UNASSIGNED
Nocardiosis, a bacterial opportunistic infection caused by
Methods UNASSIGNED
We performed a prospective, multicenter, nationwide study in France and included patients with a
Results UNASSIGNED
Twenty patients (18 [90%] male) were included, with a median age of 69 (interquartile range, 44-75) years. The organs most frequently involved were the brain (14/20 [70%]) and the lung (12/20 [60%]). Half of the infections were disseminated (10/20 [50%]).
Conclusions UNASSIGNED
Nocardiosis with anti-GM-CSF autoantibodies is associated with a low mortality rate despite a high incidence of brain involvement. Although the occurrence of aPAP was infrequent during the 1-year follow-up period, long-term clinical data are needed to fully understand the potential relationship between nocardiosis, anti-GM-CSF autoantibodies, and aPAP.

Identifiants

pubmed: 38915339
doi: 10.1093/ofid/ofae269
pii: ofae269
pmc: PMC11194753
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofae269

Investigateurs

Anne Bergeron-Lafaurie (A)
Gabrielle Carpentier-Blanc (G)
Vincent Cottin (V)
Marie Froidure (M)
Alice Hadchouel Duverge (AH)
Stéphane Jouneau (S)
Frédéric Laurent (F)
Raphael Lepeule (R)
Olivier Lortholary (O)
Matthieu Mahévas (M)
Cédric Ménard (C)
Véronica Rodriguez-Nava (V)
Julie Traclet (J)

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

Thibault Kerdiles (T)

AP-HP, Département des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, Lariboisière, Paris, France.
Faculté de Médecine, Sorbonne Université, Paris, France.

Sophie Lejeune (S)

Service de maladies infectieuses et tropicales, CHU Grenoble Alpes, Grenoble, France.

Antoine Portais (A)

Service de maladies infectieuses et tropicales, CHU Grenoble Alpes, Grenoble, France.

Gaelle Bourgeois (G)

Service de Maladies Infectieuses, Centre Hospitalier Metropole Savoie, Chambéry, France.

Benjamin Lefevre (B)

Service des Maladies Infectieuses et Tropicales, CHRU-Nancy, Université de Lorraine, Nancy, France.
Université de Lorraine, Inserm, INSPIIRE, Nancy, France.

Alexandre Charmillon (A)

Service des Maladies Infectieuses et Tropicales, CHRU-Nancy, Université de Lorraine, Nancy, France.

Thibault Sixt (T)

Infectious Diseases Department, Dijon University Hospital, Dijon, France.

Florian Moretto (F)

Infectious Diseases Department, Dijon University Hospital, Dijon, France.

Cyril Cornille (C)

Service des maladies infectieuses et tropicales, Hôpital universitaire de Clermont-Ferrand, Clermont-Ferrand, France.

Magali Vidal (M)

Service des maladies infectieuses et tropicales, Hôpital universitaire de Clermont-Ferrand, Clermont-Ferrand, France.

François Coustillères (F)

Service de Médecine Interne-Maladies Infectieuses, CHRU Tours, Tours, France.

Jean-Philippe Martellosio (JP)

Service de médecine interne, maladies infectieuses et tropicales, CHU de Poitiers, Université de Poitiers, Poitiers, France.

Marion Quenet (M)

Service de Médecine Polyvalente, Centre Hospitalier Yves Le Foll, Saint-Brieuc, France.

Martin Belan (M)

Equipe Mobile d'Infectiologie, Hôpitaux Universitaires Paris Centre-Cochin Port Royal, Assistance publique Hôpitaux de Paris (AP-HP), Paris, France.

Fanny Andry (F)

Service de Maladies Infectieuses et Dermatologie, CHU de la Réunion, Saint Pierre, France.

Karim Jaffal (K)

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Raymond Poincaré, Assistance publique Hôpitaux de Paris (AP-HP), Garches, France.

Angela Pinazo-Melia (A)

Service de pneumologie, Hôpitaux civils de Colmar, Colmar, France.

Paul Rondeau (P)

Service de Médecine interne, Hôpital Saint-Camille, Bry-sur-Marne, France.

David Luque Paz (D)

Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Bacterial Regulatory RNAs and Medicine, University of Rennes, UMR 1230, Inserm, Rennes, France.

Stephane Jouneau (S)

Department of Respiratory Medicine, CHU Rennes, Rennes, France.
Institut de recherche en santé, environnement et travail, Université Rennes, CHU Rennes, Inserm, EHESP, UMR_S 1085, Rennes, France.

Raphael Borie (R)

Service de Pneumologie A Hôpital Bichat, Assistance publique Hôpitaux de Paris (AP-HP), Université Paris Cité, Inserm, PHERE, Université Paris Cité, Paris, France.

Delphine Monnier (D)

Service d'Immunologie, CHU Rennes, Rennes, France.

David Lebeaux (D)

AP-HP, Département des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, Lariboisière, Paris, France.
Genetics of Biofilms Laboratory, Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.

Classifications MeSH